Telix Pharmaceuticals | TLX - Pre Tax Profit

Stock Price
13.64
Daily Change
-0.31 -2.22%
Monthly
24.00%
Yearly
-48.68%
Q2 Forecast
12.67

Telix Pharmaceuticals reported AUD76.73M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Cochlear AUD 121.1M 155.6M Jun/2025
CSL USD 2.61B 1.21B Dec/2025
Integral Diagnostics AUD 14.49M 47.37M Jun/2024
Mayne Pharma AUD -14.7M 42.91M Dec/2024
Medical Developments International AUD -149K 466K Jun/2025
Mesoblast USD -54.09M 6.37M Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Pacific Edge NZD -714K 49K Mar/2024
Polynovo AUD 1.96M 146K Dec/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Ramsay Health Care AUD 103.75M 54.35M Jun/2025
ResMed USD 496.15M 13.77M Dec/2025
Sonic Healthcare AUD 402.01M 53.16M Jun/2025